CD19 Primary Antibody
Item Information
Catalog #
Size
Price
Description
The CD19 antigen (95kDa) is expressed from the earliest stage of B progenitor development, on all
peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia
tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation
to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition
will influence B cell activation and proliferation.
peripheral B cells including germinal centre B cells, and all B cell lines and B cell leukaemia
tested. T cell and monocytic cell lines are negative and the antigen is lost on B cell maturation
to plasma cells. The antigen is a type I integral membrane glycoprotein whose in vitro inhibition
will influence B cell activation and proliferation.
Product Overview
Entrez GenelD
930
Aliases
B4; MGC12802
Clone#
2E2B6B10
Host / Isotype
Mouse / IgG2b
Species Reactivity
Human
Immunogen
Purified recombinant fragment of human CD19 expressed in E. Coli.
Formulation
Ascitic fluid containing 0.03% sodium azide.
Storage
4°C; -20°C for long term storage
Product Applications
WB (Western Blot)
1/500 - 1/2000
IHC_P(Immunohistochemistry)
1/200 - 1/1000
ELISA
1/10000
References
1. Rie, M.A. de, J. of Immunol. Methods, 1987. 102: 187.
2. Rie, M.A. de, Leukaemia Research, 1988. 12: 135.
2. Rie, M.A. de, Leukaemia Research, 1988. 12: 135.
Product Image
Western Blot
Figure 1: Western blot analysis using CD19 mouse mAb against CD19 recombinant protein.
Immunohistochemical analysis
Figure 2: Immunohistochemical analysis of paraffin-embedded human normal lymph node, showing cytoplasmic localization using CD19 mouse mAb with DAB staining.
For Research Use Only. Not for use in diagnostic procedures.